Status:
TERMINATED
Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass
Lead Sponsor:
The Cleveland Clinic
Conditions:
Congenital Heart Surgery
Cardiopulmonary Bypass
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
Cardiopulmonary bypass \[CPB\] in small size bodies can result in decreased peripheral perfusion. This results in anaerobic metabolism as evidenced by lactic acidosis. High flow perfusion results in s...
Detailed Description
Background Cardiopulmonary bypass \[CPB\] in small size bodies can result in decreased peripheral perfusion. This results in anaerobic metabolism as evidenced by lactic acidosis. High flow results in ...
Eligibility Criteria
Inclusion
- Patients
- The following patients are candidates for receiving PBZ for HFLPP. These include:
- All patients under 16 kg.
- Those patients between 16-18 kg whose pre bypass hemoglobin is \<16 g/dl
- All patients are less than 18 years of age
Exclusion
- Those with bloodless prime in Cardiopulmonary bypass circuit
- Age \> 18years
- Wt. \>16 kg
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT00620945
Start Date
June 1 2006
End Date
February 1 2009
Last Update
December 19 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.